Previous 10 | Next 10 |
10x Genomics (NASDAQ: TXG) , which is focused on helping researchers study genomic changes on a cellular level, beat Wall Street expectations in the first quarter, but shares of the company fell substantially. In this video from Motley Fool Live , recorded on May 10 , Fo...
I began investing seriously at the end of 2019 and have since begun researching stocks full time. After traversing 2020, I have already learned much about the market and how to move forward. This article will highlight what I believe is close to a well-rounded portfolio for the co...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Softbank (OTCMKTS: SFTBY ) is a company whose business and investments touch nearly every corner of the globe. Its Vision Fund is the largest private equity fund in the world and grabs headlines, both good and bad, o...
PLEASANTON, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences: William Blair 41 st Annual Growth Stock Conference Fireside Chat on Wednesday, June 2 nd ...
Life sciences research company 10x Genomics (NASDAQ: TXG) delivered its first-quarter numbers on May 5, reporting that it grew revenues by 47% year over year, with instrument sales up by 22% and consumables sales up by 52%. The combination of increasing consumable sales and lower li...
Gainers: Stealth BioTherapeutics (MITO) +45%, Biofrontera (BFRA) +18%, BioCryst Pharmaceuticals (BCRX) +15%, Orgenesis (ORGS) +12%, GT Biopharma (GTBP) +4%.Losers: Regional Health Properties (RHE) -24%, VYNE Therapeutics (VYNE) ...
10x Genomics (NASDAQ: TXG) has been sizzling hot for much of 2021 so far. It hasn't hurt that Cathie Wood has been busy scooping up shares of the genomics company for her ARK Innovation ETF . However, that sizzle seems likely to fizzle somewhat now. 10x Genomics announce...
10x Genomics, Inc. (TXG) Q1 2021 Earnings Conference Call May 5, 2021 4:30 p.m. ET Company Participants Eric Jaschke - Director of IR and Strategic Finance Serge Saxonov - CEO and Co-Founder Justin McAnear - CFO Brad Crutchfield - Chief Commercial Officer Conference Call Participants Doug Sch...
10x Genomics (TXG): Q1 GAAP EPS of -$0.11 beats by $0.17.Revenue of $105.8M (+47.1% Y/Y) beats by $3.04M.2021 Financial Guidance: 10x Genomics is maintaining full year 2021 revenue guidance of $480 million to $500 million vs. consensus of $495.60M, representing 61% to 67% growth over ful...
PLEASANTON, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2021. Recent Highlights Revenue was $105.8 million for the first quarter, representing a 47% increase over the co...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...